Literature DB >> 11123006

The medical management of adolescent heroin dependence.

A B Rowan1, P J Fudala, J Mulligan.   

Abstract

The use of heroin by American adolescents is at its highest levels since the heroin epidemic of the 1960s. This clinical perspective reviews medical issues associated with adolescent heroin dependence. Older, as well as potential newer, treatments for adolescent heroin dependence are discussed. Multiple obstacles face a heroin-dependent adolescent who seeks treatment, including a lack of evidenced-based research on pharmacotheraputic agents for this population, strict restrictions on medications with demonstrated efficacy in adults, and a general lack of clinical experience in treating this population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123006     DOI: 10.1007/s11920-000-0013-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  16 in total

1.  Heroin use among adolescents in treatment for substance use disorders.

Authors:  C J Hopfer; S K Mikulich; T J Crowley
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-10       Impact factor: 8.829

2.  Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial.

Authors:  L San; J Camí; J M Peri; R Mata; M Porta
Journal:  Br J Addict       Date:  1990-01

3.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

4.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.

Authors:  D R Jasinski; J S Pevnick; J D Griffith
Journal:  Arch Gen Psychiatry       Date:  1978-04

5.  Adolescents and short term, low dose methadone maintenance.

Authors:  G G DeAngelis; W X Lehmann
Journal:  Int J Addict       Date:  1973

6.  Buprenorphine effects on human heroin self-administration: an operant analysis.

Authors:  N K Mello; J H Mendelson; J C Kuehnle
Journal:  J Pharmacol Exp Ther       Date:  1982-10       Impact factor: 4.030

7.  Sublingual versus subcutaneous buprenorphine in opiate abusers.

Authors:  D R Jasinski; P J Fudala; R E Johnson
Journal:  Clin Pharmacol Ther       Date:  1989-05       Impact factor: 6.875

Review 8.  Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.

Authors:  M S Gold
Journal:  Psychiatr Clin North Am       Date:  1993-03

9.  Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin.

Authors:  J Camí; S de Torres; L San; A Solé; D Guerra; B Ugena
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

10.  The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.

Authors:  D S Charney; D E Sternberg; H D Kleber; G R Heninger; D E Redmond
Journal:  Arch Gen Psychiatry       Date:  1981-11
View more
  1 in total

1.  Pharmacologically assisted treatment of opioid-dependent youth.

Authors:  Anna Pecoraro; Marc Fishman; Michelle Ma; Gvantsa Piralishvili; George E Woody
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.